The two highly immunogenic antigens of Brucella: lipopolysaccharide (LPS) and outer membrane proteins (OMPs)
暂无分享,去创建一个
Suk Kim | H. T. Hop | L. T. Arayan | T. X. N. Huy | W. Min | H. Simborio | A. Reyes
[1] David J. Sherman,et al. Lipopolysaccharide transport to the cell surface: periplasmic transport and assembly into the outer membrane , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.
[2] Jin Ju Lee,et al. Evaluation of the combined use of the recombinant Brucella abortus Omp10, Omp19 and Omp28 proteins for the clinical diagnosis of bovine brucellosis. , 2015, Microbial pathogenesis.
[3] G. Briones,et al. Development of a dual vaccine for prevention of Brucella abortus infection and Escherichia coli O157:H7 intestinal colonization. , 2015, Vaccine.
[4] P. Chaudhuri,et al. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice. , 2015, Vaccine.
[5] Fukun Zhao,et al. Identification of a novel vaccine candidate by immunogenic screening of Vibrio parahaemolyticus outer membrane proteins. , 2014, Vaccine.
[6] I. Moriyón,et al. The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortus. , 2014, Microbial pathogenesis.
[7] C. Whitfield,et al. Biosynthesis and export of bacterial lipopolysaccharides. , 2014, Annual review of biochemistry.
[8] C. Ding,et al. Mechanism of Asp24 Upregulation in Brucella abortus Rough Mutant with a Disrupted O-Antigen Export System and Effect of Asp24 in Bacterial Intracellular Survival , 2014, Infection and Immunity.
[9] Jie-Oh Lee,et al. Recognition of lipopolysaccharide pattern by TLR4 complexes , 2013, Experimental & Molecular Medicine.
[10] A. Omar,et al. Clinico-pathological changes associated with Brucella melitensis infection and its bacterial Lipopolysaccharides (LPS) in male mice , 2013 .
[11] J. Timoney,et al. Detection of LipL32-specific IgM by ELISA in sera of patients with a clinical diagnosis of leptospirosis , 2013, Pathogens and global health.
[12] Jin Ju Lee,et al. Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice , 2012, Journal of veterinary science.
[13] Jin Ju Lee,et al. Evaluation of recombinant 28 kDa outer membrane protein of Brucella abortus for the clinical diagnosis of bovine brucellosis in Korea. , 2012, The Journal of veterinary medical science.
[14] N. Khoramabadi,et al. Recombinant Brucella abortus outer membrane protein 19 (rOmp19) significantly stimulates splenic lymphocytes of immunized BALB/c mice , 2012 .
[15] Anna R Martirosyan,et al. The Lipopolysaccharide Core of Brucella abortus Acts as a Shield Against Innate Immunity Recognition , 2012, PLoS pathogens.
[16] T. Ficht,et al. Lipopolysaccharide: a complex role in the pathogenesis of brucellosis. , 2011, Veterinary journal.
[17] S. M. Sadat,et al. Biological and immunological characteristics of Brucella abortus S99 major outer membrane proteins , 2011 .
[18] J. Tommassen,et al. Assembly of outer-membrane proteins in bacteria and mitochondria. , 2010, Microbiology.
[19] K. Ravikumar,et al. Brucellosis: Review on the Recent Trends in Pathogenicity and Laboratory Diagnosis , 2010, Journal of laboratory physicians.
[20] Fernanda S. Oliveira,et al. The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis , 2010, The Journal of Immunology.
[21] Te‐Li Chen,et al. Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae. , 2010, The Journal of antimicrobial chemotherapy.
[22] S. Naqvi,et al. Outer membrane proteins of Brucella abortus vaccinal and field strains and their immune response in buffaloes. , 2010 .
[23] D. Spring,et al. The molecular basis of the host response to lipopolysaccharide , 2010, Nature Reviews Microbiology.
[24] T. Pál,et al. Lipopolysaccharide: a tool and target in enterobacterial vaccine development , 2008, Biological chemistry.
[25] A. Gross,et al. Interaction of Brucella suis and Brucella abortus Rough Strains with Human Dendritic Cells , 2007, Infection and Immunity.
[26] A. Gross,et al. Brucella suis Prevents Human Dendritic Cell Maturation and Antigen Presentation through Regulation of Tumor Necrosis Factor Alpha Secretion , 2007, Infection and Immunity.
[27] D. Hoover,et al. Comparison of Protective Efficacy of Subcutaneous versus Intranasal Immunization of Mice with a Brucella melitensis Lipopolysaccharide Subunit Vaccine , 2006, Infection and Immunity.
[28] F. Hassan,et al. Characterization of Biological Activities of Brucella melitensis Lipopolysaccharide , 2006, Microbiology and immunology.
[29] V. Azevedo,et al. Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system , 2006, Microbial cell factories.
[30] S. Estein,et al. A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection against B. melitensis and B. ovis Infection by Eliciting a Specific Cytotoxic Response , 2005, Infection and Immunity.
[31] P. Bhattarakosol,et al. LipL32, an outer membrane protein of Leptospira, as an antigen in a dipstick assay for diagnosis of leptospirosis. , 2005, Asian Pacific journal of allergy and immunology.
[32] C. Lambert,et al. Functional, molecular and structural characterisation of five anti-Brucella LPS mAb. , 2004, Molecular immunology.
[33] H. Nikaido. Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.
[34] C. Weise,et al. Characterization of New Members of the Group 3 Outer Membrane Protein Family of Brucella spp , 2003, Infection and Immunity.
[35] G. Splitter,et al. Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans , 2003, Clinical Microbiology Reviews.
[36] J. Paquet,et al. Major outer membrane proteins of Brucella spp.: past, present and future. , 2002, Veterinary microbiology.
[37] G. Splitter,et al. Virulence Criteria for Brucella abortus Strains as Determined by Interferon Regulatory Factor 1-Deficient Mice , 2002, Infection and Immunity.
[38] Elliott Bennett-Guerrero,et al. Structure and function of lipopolysaccharides. , 2002, Microbes and infection.
[39] S. Hagius,et al. Attenuation of a Brucella abortus mutant lacking a major 25 kDa outer membrane protein in cattle. , 2001, American journal of veterinary research.
[40] C. Baldwin,et al. Interferon‐γ is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice , 2001, Immunology.
[41] E. Rietschel,et al. Invited review: Bacterial lipopolysaccharides and innate immunity , 2001 .
[42] P. van Gelder,et al. Structure and function of bacterial outer membrane proteins: barrels in a nutshell , 2000, Molecular microbiology.
[43] A. Alonso,et al. Lipopolysaccharides of Brucella abortusand Brucella melitensis Induce Nitric Oxide Synthesis in Rat Peritoneal Macrophages , 2000, Infection and Immunity.
[44] R. Vemulapalli,et al. Characterization of Specific Immune Responses of Mice Inoculated with Recombinant Vaccinia Virus Expressing an 18-Kilodalton Outer Membrane Protein of Brucella abortus , 2000, Clinical Diagnostic Laboratory Immunology.
[45] J. Letesson,et al. Outer Membrane Proteins Omp10, Omp16, and Omp19 of Brucella spp. Are Lipoproteins , 1999, Infection and Immunity.
[46] I. Moriyón,et al. Structure and properties of the outer membranes of Brucella abortus and Brucella melitensis. , 1998, International microbiology : the official journal of the Spanish Society for Microbiology.
[47] A. Weintraub,et al. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts , 1996, Journal of bacteriology.